Sinning K M, Jude D C, Yoost J L
Marshall University, Department of Obstetrics and Gynecology, 1600 Medical Center Dr Suite 4500, Huntington, West Virginia.
Marshall University, Department of Obstetrics and Gynecology, 1600 Medical Center Dr Suite 4500, Huntington, West Virginia.
J Pediatr Adolesc Gynecol. 2018 Aug;31(4):400-404. doi: 10.1016/j.jpag.2018.02.127. Epub 2018 Feb 17.
To quantify the "normal" adolescent experience after intrauterine device insertion, to provide appropriate counseling for future adolescents.
Prospective cohort study.
Marshall University Department of Obstetrics and Gynecology generalist and adolescent gynecology clinics.
Nulliparous adolescents age 13-18 years and parous adults 18 years of age or older who received a levonorgestrel intrauterine system (LNG-IUS).
Visual analogue scale (VAS) pain score and medication log was used for data collection for 2 weeks after LNG-IUS insertion. A separate chart review was completed for demographic factors and indications for procedure.
VAS pain scores and medication use was compared between groups.
Ninety-three subjects returned the VAS record and medication log (46 adolescents and 47 adults). There was no difference in the incidence of endometriosis or dysmenorrhea, but there was a higher prevalence of menorrhagia among adolescents (30/46, 65.2% vs 10/47, 21.3%; P < .001). Forty-five of forty-seven (95.7%) adults vs 25/46 (54.3%) adolescents had contraception as an indication for intrauterine device use (P < .001). Pain scores were statistically higher among the adolescent group each day (P < .05) in the 2-week study period. The greatest mean differences occurred in the first 4 days. More adolescents (15/46, 32.6%) than adults (6/47, 12.8%) had a pain score greater than 5 during the first 3 days (P = .022). A statistical difference in amount of ibuprofen recorded was only noted on day 1 (P = .023) and day 4 (P = .046).
Nulliparous adolescents who undergo LNG-IUS placement experience more postinsertional discomfort compared with parous adults; however, this method should still be considered first-line treatment in this age group.
量化宫内节育器放置后“正常”的青少年体验,为未来的青少年提供适当的咨询服务。
前瞻性队列研究。
马歇尔大学妇产科普通科及青少年妇科诊所。
13 - 18岁未生育的青少年以及18岁及以上已生育的成年人,他们均接受了左炔诺孕酮宫内节育系统(LNG-IUS)。
在LNG-IUS放置后2周,使用视觉模拟量表(VAS)疼痛评分和用药记录来收集数据。针对人口统计学因素和手术指征完成了单独的病历回顾。
比较两组之间的VAS疼痛评分和用药情况。
93名受试者返回了VAS记录和用药记录(46名青少年和47名成年人)。子宫内膜异位症或痛经的发生率没有差异,但青少年中月经过多的患病率更高(30/46,65.2%对10/47,21.3%;P <.001)。47名成年人中有45名(95.7%)与46名青少年中的25名(54.3%)将避孕作为使用宫内节育器的指征(P <.001)。在为期2周的研究期间,青少年组每天的疼痛评分在统计学上更高(P <.05)。最大的平均差异出现在前4天。在头3天内,疼痛评分大于5的青少年(15/46,32.6%)比成年人(6/47,12.8%)更多(P = 0.022)。仅在第1天(P = 0.023)和第4天(P = 0.046)记录的布洛芬用量存在统计学差异。
与已生育的成年人相比,接受LNG-IUS放置的未生育青少年术后不适更多;然而,这种方法仍应被视为该年龄组的一线治疗方法。